The artificial lung (AL) technology is one of the membrane-based artificial organs that partly
augments lung functions, ie blood oxygenation and CO 2 removal. It is generally employed …

The increasing prevalence of chronic lung disease worldwide, combined with the
emergence of multiple pandemics arising from respiratory viruses over the past century …

Preterm neonates suffering from respiratory distress syndrome require assistive support in
the form of mechanical ventilation or extracorporeal membrane oxygenation, which may …

State of the art artificial membrane lungs incorporate hollow fiber membranes. The creeping
blood flow in hollow fiber bundles forms a boundary layer that represents a diffusive …

Objective: Microfluidic artificial lungs (μALs) are being researched for future clinical use due
to the potential for increased gas exchange efficiency, small blood contacting surface area …

Many neonates who are born premature suffer from respiratory distress syndrome (RDS) for
which mechanical ventilation and an extracorporeal membrane oxygenation (ECMO) device …

Preterm neonates with immature lungs require a lung assist device (LAD) to maintain
oxygen saturation at normal levels. Over the last decade, microfluidic blood oxygenators …

Microfluidic artificial lungs (µALs) have the potential to improve the treatment and quality of
life for patients with acute or chronic lung injury. In order to realize the full potential of this …

Premature neonates suffer from respiratory morbidity as their lungs are immature, and
current supportive treatment such as mechanical ventilation or extracorporeal membrane …

Separation membranes play a crucial role in the functioning of artificial organs, such as
hemodialysis machines, membrane oxygenators, and artificial liver models. The current …